• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国的精神活性物质使用情况。

The Use of Psychoactive Substances in Germany.

机构信息

IFT Institut für Therapieforschung, Munich; Psychology Department, University of Arizona, Tucson, USA; Department of Public Health Sciences, Stockholm University, Stockholm, Sweden; Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary.

出版信息

Dtsch Arztebl Int. 2022 Aug 8;119(31-32):527-534. doi: 10.3238/arztebl.m2022.0244.

DOI:10.3238/arztebl.m2022.0244
PMID:35791270
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9677535/
Abstract

BACKGROUND

Monitoring the use of psychoactive substances and substance-related problems in the population allows for the assessment of prevalence and associated health and social consequences.

METHODS

The data are derived from the Epidemiological Survey of Substance Abuse (ESA) 2021 (n = 9046, 18-64 years). We estimated prevalence rates of the use of tobacco, alcohol, illegal drugs, and psychoactive medications, as well as the prevalence rates of their problematic use (indicating dependence) using screening instruments, and extrapolated the results to the resident population (N = 51 139 451).

RESULTS

Alcohol was the most frequently used substance, with a 30-day prevalence of 70.5% (36.1 million people), followed by non-opioid analgesic drugs (47.4%; 24.2 million) and conventional tobacco products (22.7%; 11.6 million). E-cigarettes were used by 4.3% (2.2 million) and heat-not-burn products by 1.3% (665 000). Among illegal drugs (12-month prevalence), cannabis was the most frequently used (8.8%; 4.5 million), followed by cocaine/crack (1.6%; 818 000) and amphetamine (1.4%; 716 000). Rates of problematic use among the study participants were 17.6% for alcohol (9.0 million), 7.8% for tobacco (4.0 million), 5.7% for psychoactive medications (2.9 million), and 2.5% for cannabis (1.3 million).

CONCLUSION

The consumption of psychoactive substances continues to be widespread in Germany. In view of the imminent legal changes, the high prevalence of cannabis use and its problematic use need to be taken into consideration.

摘要

背景

监测人群中精神活性物质的使用和与物质相关的问题,可以评估其流行程度以及相关的健康和社会后果。

方法

数据来自 2021 年的《物质滥用流行病学调查》(ESA)(n=9046,年龄 18-64 岁)。我们使用筛查工具估计了烟草、酒精、非法药物和精神活性药物的使用流行率,以及其问题使用(表明依赖)的流行率,并将结果外推至居民人口(N=51139451)。

结果

酒精是最常使用的物质,30 天使用率为 70.5%(3610 万人),其次是非阿片类镇痛药(47.4%;2420 万人)和常规烟草制品(22.7%;1160 万人)。电子烟使用率为 4.3%(220 万人),加热不燃烧产品为 1.3%(66.5 万人)。在非法药物(12 个月流行率)中,大麻的使用率最高(8.8%;450 万人),其次是可卡因/快克(1.6%;81.8 万人)和安非他命(1.4%;71.6 万人)。研究参与者中酒精(900 万人)、烟草(400 万人)、精神活性药物(290 万人)和大麻(130 万人)的问题使用率分别为 17.6%、7.8%、5.7%和 2.5%。

结论

精神活性物质的消费在德国仍很普遍。鉴于即将发生的法律变化,需要考虑大麻使用及其问题使用的高流行率。

相似文献

1
The Use of Psychoactive Substances in Germany.德国的精神活性物质使用情况。
Dtsch Arztebl Int. 2022 Aug 8;119(31-32):527-534. doi: 10.3238/arztebl.m2022.0244.
2
The Use of Alcohol, Tobacco, Illegal Drugs and Medicines: An Estimate of Consumption and Substance-Related Disorders in Germany.《酒精、烟草、非法药物和药物的使用:德国消费和物质相关障碍的估计》。
Dtsch Arztebl Int. 2019 Sep 2;116(35-36):577-584. doi: 10.3238/arztebl.2019.0577.
3
[Weighing the benefits and harms of psychotropic and analgesic substances - A perspective of German addiction medicine experts].权衡精神药物和镇痛药物的利弊——德国成瘾医学专家的观点
Fortschr Neurol Psychiatr. 2022 Jan;90(1-02):19-29. doi: 10.1055/a-1363-0223. Epub 2021 Feb 25.
4
[Epidemiology of substance use and substance use disorders in Germany].[德国物质使用及物质使用障碍的流行病学]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Apr;53(4):271-83. doi: 10.1007/s00103-010-1041-z.
5
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report.全球酒精、烟草和非法药物使用统计数据:2017 年现状报告。
Addiction. 2018 Oct;113(10):1905-1926. doi: 10.1111/add.14234. Epub 2018 Jun 4.
6
Prevalence of consumption of psychoactive substances amongst dockers.码头工人中精神活性物质的消费流行情况。
Int Marit Health. 2018;69(2):118-125. doi: 10.5603/IMH.2018.0017.
7
Prevalence of psychoactive substances, alcohol and illicit drugs, in Spanish drivers: A roadside study in 2015.西班牙驾驶员中精神活性物质、酒精和非法药物的流行情况:2015年的一项路边研究
Forensic Sci Int. 2017 Sep;278:253-259. doi: 10.1016/j.forsciint.2017.07.005. Epub 2017 Jul 20.
8
Trends In Substance Use And Related Disorders: Analysis of the Epidemiological Survey of Substance Abuse 1995 to 2018.趋势中的物质使用和相关障碍:滥用物质的流行病学调查 1995 年至 2018 年的分析。
Dtsch Arztebl Int. 2019 Sep 2;116(35-36):585-591. doi: 10.3238/arztebl.2019.0585.
9
Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.在已知或疑似父母滥用传统非法药物的家庭中,父母及子女毛发中卡西酮和其他新型精神活性物质的流行情况。
Forensic Sci Int. 2022 Feb;331:111148. doi: 10.1016/j.forsciint.2021.111148. Epub 2021 Dec 10.
10
COgnitive enhancement and consumption of psychoactive Substances among Youth Students (COSYS): a cross-sectional study in France.青少年认知增强与精神活性物质使用(COSYS):法国的一项横断面研究。
Public Health. 2021 May;194:75-78. doi: 10.1016/j.puhe.2021.02.036. Epub 2021 Apr 14.

引用本文的文献

1
Age-period-cohort analysis of past 12-month cannabis use in Germany (1995-2021).德国过去12个月大麻使用情况的年龄-时期-队列分析(1995 - 2021年)
Addiction. 2025 Jun 19. doi: 10.1111/add.70087.
2
Population-based estimates of different dosage types of psychedelic use across socio-demographic groups in Germany.基于德国不同社会人口群体的迷幻剂使用不同剂量类型的人群估计。
Sci Rep. 2025 May 29;15(1):18952. doi: 10.1038/s41598-025-03873-0.
3
[Development of cannabis use from adolescence to young adulthood and risk and protective factors for problematic use-results of a longitudinal study].[从青少年到青年期大麻使用的发展以及问题使用的风险和保护因素——一项纵向研究的结果]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 May;68(5):548-559. doi: 10.1007/s00103-025-04043-3. Epub 2025 Apr 15.
4
Unseen dualities: underdiagnosis of substance use disorders in borderline personality disorder.隐匿的双重性:边缘型人格障碍中物质使用障碍的诊断不足
Front Psychiatry. 2025 Mar 25;16:1539611. doi: 10.3389/fpsyt.2025.1539611. eCollection 2025.
5
Cannabis Consumption Rates were Underestimated.大麻消费率被低估了。
Dtsch Arztebl Int. 2024 Sep 6;121(18):612. doi: 10.3238/arztebl.m2024.0092.
6
Clinical course and demographic insights into suicide by self-poisoning: patterns of substance use and socio-economic factors.通过自我中毒自杀的临床过程及人口统计学洞察:物质使用模式和社会经济因素
Soc Psychiatry Psychiatr Epidemiol. 2025 Mar;60(3):705-718. doi: 10.1007/s00127-024-02750-x. Epub 2024 Sep 24.
7
[Cannabis use and cannabis use disorders].[大麻使用与大麻使用障碍]
Nervenarzt. 2024 Sep;95(9):781-796. doi: 10.1007/s00115-024-01722-5. Epub 2024 Aug 12.
8
Predictors of changes in marijuana consumption in Germany during the covid-19 pandemic.新冠疫情期间德国大麻消费变化的预测因素
Eur Arch Psychiatry Clin Neurosci. 2025 Mar;275(2):389-396. doi: 10.1007/s00406-024-01861-5. Epub 2024 Jul 6.
9
Cannabis-related treatment demand at the eve of German cannabis legalization - a 20-years trend analysis.德国大麻合法化前夕与大麻相关的治疗需求——一项20年趋势分析
Eur Arch Psychiatry Clin Neurosci. 2025 Mar;275(2):365-378. doi: 10.1007/s00406-024-01832-w. Epub 2024 Jul 1.
10
Road safety implications of the partial legalisation of cannabis in Germany: protocol for a quasi-experimental study.德国大麻部分合法化对道路安全的影响:一项准实验研究方案
BMJ Open. 2024 Jun 13;14(6):e084611. doi: 10.1136/bmjopen-2024-084611.

本文引用的文献

1
Changes in the Use of Tobacco, Alternative Tobacco Products, and Tobacco Alternatives in Germany.德国烟草使用、替代烟草产品和烟草替代品的变化。
Dtsch Arztebl Int. 2022 Aug 8;119(31-32):535-541. doi: 10.3238/arztebl.m2022.0252.
2
Abuse of Non-opioid Analgesics in Germany: Prevalence and Associations Among Self-Medicated Users.德国非阿片类镇痛药的滥用:自我用药者中的患病率及关联
Front Psychiatry. 2022 Apr 25;13:864389. doi: 10.3389/fpsyt.2022.864389. eCollection 2022.
3
Incidence of inpatient cases with mental disorders due to use of cannabinoids in Germany: a nationwide evaluation.德国因使用大麻素导致的住院精神障碍病例发生率:一项全国性评估。
Eur J Public Health. 2022 Apr 1;32(2):239-245. doi: 10.1093/eurpub/ckab207.
4
Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates.欧洲大麻使用的公共卫生监测:使用率、大麻效力及治疗率
Lancet Reg Health Eur. 2021 Sep 24;10:100227. doi: 10.1016/j.lanepe.2021.100227. eCollection 2021 Nov.
5
Alcohol consumption and associations with sociodemographic and health-related characteristics in Germany: A population survey.德国的饮酒情况及与社会人口学和健康相关特征的关系:一项人口调查。
Addict Behav. 2022 Feb;125:107159. doi: 10.1016/j.addbeh.2021.107159. Epub 2021 Oct 19.
6
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年吸烟流行率、时空分布特征及归因疾病负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet. 2021 Jun 19;397(10292):2337-2360. doi: 10.1016/S0140-6736(21)01169-7. Epub 2021 May 27.
7
Cardiorespiratory and Immunologic Effects of Electronic Cigarettes.电子烟对心肺和免疫的影响。
Curr Addict Rep. 2021;8(2):336-346. doi: 10.1007/s40429-021-00359-7. Epub 2021 Mar 5.
8
Trajectories of alcohol-induced blackouts in adolescence: early risk factors and alcohol use disorder outcomes in early adulthood.青少年期酒精所致昏迷的轨迹:早期风险因素与成年早期的酒精使用障碍结局。
Addiction. 2021 Aug;116(8):2039-2048. doi: 10.1111/add.15415. Epub 2021 Feb 1.
9
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
10
E-cigarettes use in the United States: reasons for use, perceptions, and effects on health.美国电子烟使用情况:使用原因、认知和对健康的影响。
BMC Public Health. 2020 Oct 9;20(1):1518. doi: 10.1186/s12889-020-09572-x.